Benitec Biopharma BNTC Ratios (2019-2025)

NASDAQ BNTC
$12.76 +0.32 (+2.57%)
As of: Sep 4, 2026 · 3:12 PM EDT
Reported Financials

Benitec Biopharma Quarterly Ratios

Periods 27 quarters
Latest Dec 2025

Benitec Biopharma ratios data for the quarter ended Dec 2025. These financial ratios cover 27 quarters of results from Jun 2019 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
EBT Margin
-379,500.00%-192,800.00%-19,384.00%-7,229.17%-40,135.71%-8,051.85%-65,114.29%
EBIT Margin
-379,300.00%-192,750.00%-19,340.00%-7,208.33%-40,071.43%-8,038.89%-65,000.00%
EBITDA Margin
-379,300.00%-192,750.00%-19,340.00%-7,208.33%-40,071.43%-8,038.89%-65,000.00%
Operating Margin
-379,300.00%-192,750.00%-19,340.00%-7,208.33%-40,071.43%-8,038.89%-65,000.00%
Net Margin
-379,500.00%-192,800.00%-19,384.00%-7,229.17%-40,135.71%-8,051.85%-65,114.29%
FCF Margin
-201,500.00%-249,550.00%-13,288.00%-7,129.17%-41,821.43%-7,438.89%-58,514.29%
Efficiency
Assets AverageAssets Avg.
14.47M17.40M19.61M15.93M12.04M8.02M12.04M15.01M10.06M6.34M15.76M24.20M18.18M33.60M60.49M73.92M92.14M102.40M97.81M143.35M
Asset Utilization RatioAsset Util.
0.000.000.000.000.010.010.010.000.010.010.000.000.00
Valuation
Price to EarningsP/E
-6.56-4.73-6.05-4.42-5.50-2.00-0.88-0.85-1.35-1.23-1.17-1.23-3.34-6.01-19.34-31.01-53.69-26.24-64.98-52.31
Price to SalesP/S
0.02M0.01M856.34397.49339.75108.75802.78
Price to BookP/B
2.280.911.891.982.543.290.280.531.2527.820.350.541.240.601.523.905.154.356.223.30
Enterprise Value
12.92M-1.53M13.44M9.08M10.45M5.40M-12.51M-5.79M-0.74M3.13M-18.21M-12.04M14.29M-22.55M29.92M217.83M398.52M325.79M487.93M430.31M
EV to EBIT
-3.410.40-2.79-1.88-3.02-1.142.731.030.17-0.693.101.74-3.454.06-5.17-20.16-39.12-33.13-49.77-32.17
EV to EBITDA
-3.410.40-2.79-1.88-3.02-1.142.731.030.17-0.693.101.74-3.454.06-5.17-20.16-39.12-33.13-49.77-32.17
Market Capitalization
24.91M18.25M29.17M21.41M19.08M9.48M4.03M4.76M5.87M5.62M7.70M8.37M14.31M28.38M97.82M296.19M502.18M423.65M582.54M619.22M
Price to FCFP/FCF
-12.36-3.66-6.78-6.44-5.58-1.95-1.00-0.81-1.46-1.37-1.67-1.57-2.32-8.62-21.27-38.47-161.68-51.66-171.34-166.15
EV to FCF
-6.410.31-3.13-2.73-3.05-1.113.090.990.18-0.763.962.25-2.326.85-6.50-28.29-128.31-39.73-143.51-115.46
EV to CFO
-6.460.30-3.13-2.73-3.05-1.113.090.990.18-0.763.962.25-2.326.85-6.50-28.29-128.55-39.73-143.51-115.46
Return Ratios
Return on Sales [ROS]ROS
-379,300.00%-192,750.00%-393,225.00%-19,340.00%-7,208.33%-24,458.90%-24,127.40%-40,071.43%-8,038.89%-65,000.00%-27,166.67%-35,560.66%-307,028.57%
Return on Capital Employed [ROCE]ROCE
-105.01%-84.80%-87.35%-128.71%-167.54%-325.44%-194.99%-146.86%-278.88%-807.15%-181.52%-117.53%-145.82%-78.42%-40.06%-37.11%-37.99%-36.40%-42.42%-30.74%
Return on Assets [ROA]ROA
-87.24%-78.16%-80.25%-108.76%-141.17%-223.07%-146.57%-122.76%-191.84%-301.39%-129.49%-89.74%-118.38%-64.24%-34.54%-32.39%-31.65%-32.55%-37.76%-27.16%